Jitendra Gour

Employment

• The Wistar Institute Postdoctoral Research Associate
  2021 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (31)

• Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
  2025 DOI: 10.1158/2159-8290.30859506
  +Save
• A Tandem-Affinity Purification Method for Identification of Primary Intracellular Drug-Binding Proteins
  ACS Chemical Biology 2024 DOI: 10.1021/acschembio.3c00570
  +Save
• Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
  2023 DOI: 10.1158/2159-8290.22435710.v1
  +Save
• Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
  2023 DOI: 10.1158/2159-8290.22435710
  +Save
• Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
  2023 DOI: 10.1158/2159-8290.c.6515061.v1
  +Save
• Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
  2023 DOI: 10.1158/2159-8290.22553338
  +Save
• Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
  2023 DOI: 10.1158/2159-8290.22553338.v1
  +Save
• Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
  2023 DOI: 10.1158/2159-8290.c.6515061.v2
  +Save
• Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
  Cancer Discovery 2023 DOI: 10.1158/2159-8290.cd-22-1131
  +Save
• Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
  2023 DOI: 10.1158/2159-8290.22758848.v1
  +Save